News & Updates
News
Three kinds of health measures blue states are pursuing this year
BY MCKENZIE BEARD with research by RACHEL ROUBEINPUBLISHED: WEDNESDAY, FEBRUARY 22ND, 2023 Happy Wednesday and welcome back to The Health 202, where the early blooming cherry trees in the District have us excited for spring on this chilly morning. Today’s edition: The results are in for the closely watched Wisconsin Supreme Court primary election. Abortion rights groups in Ohio took the first […]
New Mexico can lead to lower prescription drug prices
BY BARBARA WEBBERPUBLISHED: SUNDAY, NOVEMBER 20TH, 2022 Gov. Michelle Lujan Grisham’s reelection is good news for New Mexicans concerned about the high cost of prescription drugs. The governor’s Prescription Drug Task Force recently made several important recommendations for the state to help make prescription drugs more affordable and accessible for New Mexicans. When the Legislature convenes […]
Pin down candidates on prescription drug affordability
BY JAMES JIMENEZPUBLISHED: SATURDAY, OCTOBER 15TH, 2022 The fall campaign season is here. This is when legislative and statewide candidates should start getting specific about solutions to the real problems New Mexicans face every day. It’s no secret that rising prices on everything from housing to groceries are hurting families. One issue that should be at […]
Inflation Reduction Act signed by President Biden to reduce cost for prescription drugs
BY KARIN SANCHEZPUBLISHED: WEDNESDAY, AUGUST 17TH, 2022 LAS CRUCES, N.M. (KFOX14/CBS4) — New Mexico Governor Michelle Lujan Grisham, the U.S. Secretary of Health and Human Services Xavier Becerra, and U.S. Senators Ben Ray Lujan and Martin Heinrich discussed with the community in a closed-off roundtable how the Inflation Reduction Act will lower the price of prescription drugs. […]
NEWS RELEASE: Consumer and health advocates call for passage of Prescription Drug Affordability Act
LAS CRUCES, NM – New Mexico Consumers for Affordable Prescriptions today called for the creation of a Prescription Drug Affordability Board at a roundtable discussion with the state’s congressional delegation and Governor Michelle Lujan Grisham, advocating that all New Mexicans would benefit from an independent board with the authority to evaluate the cost of medications […]
Time for NM Prescription Drug Affordability Board
BY BARBARA WEBBER AND ALEX CVIJANOVICH / ALBUQUERQUE JOURNALPUBLISHED: TUESDAY, AUGUST 2ND, 2022 As Congress debates adding a prescription drug provision to the budget reconciliation, one thing is certain – while important, proposed federal action to allow Medicare to negotiate drug prices will not go far enough to improve access to affordable medications for New Mexicans. […]
Board can make prescription drugs more affordable in New Mexico
BY BARBARA WEBBER AND ALEX CVIJANOVICH / SANTA FE NEW MEXICANPUBLISHED: SUNDAY, JULY 31ST, 2022 As Congress debates a prescription drug provision, one thing is certain: While important, proposed federal action to allow Medicare to negotiate drug prices will not go far enough to improve access to affordable medications for New Mexicans. We need state action […]
Gov. should add drug oversight board to agenda
BY REP. PAMELYA HERNDON / ALBUQUERQUE DEMOCRATPUBLISHED: WEDNESDAY, JANUARY 19TH, 2022 AT 12:02AM In a first for New Mexico, lawmakers put the pharmaceutical industry on the hot seat recently with a daylong hearing on the high cost of prescription drugs, and the Legislative Health and Human Services Committee stood up for New Mexico patients and consumers […]
NEWS RELEASE – New Mexicans call on Gov. Lujan Grisham to Prioritize Prescription Drug Affordability Act
January 13, 2022 FOR IMMEDIATE RELEASE CONTACT: Barbara Webber, Executive Director, Health Action New Mexico 505-508-6531 (cell) barbara@healthactionnm.org SANTA FE, NM – More than 1,000 New Mexicans are calling on Governor Michelle Lujan Grisham to make prescription drug affordability a priority for the upcoming legislative session. New Mexico Consumers for Affordable Prescriptions (NMCAP) delivered the petition signatures […]
Oregon’s new drug price transparency project finds eye-popping prescription costs
Joan Morgan’s father faced a $10,000 a month price tag for a drug to keep him alive after he was found to suffer from a rare genetic mutation, she told Oregon regulators earlier this month. But that figure pales in comparison to other high-cost drugs detailed in a new state report previewed at the hearing, which was held by the state’s Prescription Drug Price Transparency Program.